Flagship Private Wealth, LLC Viatris Inc Transaction History

Flagship Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$13.25 - $15.13 $1,802 - $2,057	-136 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$12.97 - $16.15 $23,060 - $28,714	-1,778 Reduced 92.89%	136 $1.91 Million
Q2 2021 Jul 09, 2021	BUY	$12.97 - $16.15 $23,060 - $28,714	1,778 Added 1307.35%	1,914 $27,000
Q1 2021 Apr 09, 2021	SELL	$13.59 - $18.54 $40 - $55	-3 Reduced 2.16%	136 $1.91 Million
Q4 2020 Feb 02, 2021	BUY	$14.3 - $18.74 $1,987 - $2,604	139 New	139 $2,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.